Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
![Foto de Jose Luis](/img/nophoto.png)
![Foto de Institut d'Investigacions Biomèdiques August Pi i Sunyer](/img/noimage_org.png)
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigacions Biomèdiques August Pi i Sunyer (2)
2022
2021
-
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
European Journal of Cancer, Vol. 148, pp. 382-394